Abstract
In a patient with the occipitoparietal form of Creutzfeldt-Jakob disease (CJD) (Heidenhain type) positron emission tomography (PET) demonstrated decreased glucose utilization in the occipital lobes and adjacent cortical regions. Single photon emission computed tomography (SPECT) with99mTc-bicisate showed a “coupled” decrease in blood flow in identical cortical areas in this patient. In contrast, magnetic resonance imaging (MRI) was normal. In the early stage of CJD, when still no major morphological abnormalities can be observed, functional imaging is useful for differential diagnosis, particularly to exclude other causes of dementia or pathological EEG patterns.
Similar content being viewed by others
References
Brown P, Cathala F, Castaigne P, Gajdusek DC. Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases.Ann Neurol 20: 597–602, 1986.
Prusiner SB, De Armond SJ. Prion diseases of the central nervous system.Monogr Pathol 32: 86–122, 1990.
Brown P, Goldfarb LG, Gajdusek DC. The new biology of spongiform encephalopathy: infectious amyloidosis with a genetic twist.Lancet 337: 1019–1022, 1991.
Fraser H, Dickinson AG. Targeting of scrapie lesions and spread of agent via the retino-tectal projection.Brain Res 346: 32–41, 1985.
Ter Meulen V, Kiessling WR. Slow-Virus-Erkrankungen des Menschen.In Neurologie in Praxis und Klinik, Hopf HC, Poeck K, Schliak H (eds.), 2nd ed., Stuttgart-New York, Georg Thieme Verlag, pp. 8.57–8.64, 1992.
Holman BL, Carvalho PA, Zimmermann RE, Johnson KA, Tumeh SS, Smith AP, et al. Brain perfusion SPECT using an annular single crystal camera: initial clinical experience.J Nucl Med 31: 1456–1561, 1990.
Heidenhain A. Klinische und anatomische Untersuchungen über eine eigenartige Erkrankung des Zentralnervensystems im Praesenium.Z Ges Neurol Psychiat 118: 49, 1929.
Jones HR, Hedley-Whyte ET, Freidberg SR, Baker RA. Ataxic Creutzfeldt Jakob disease: diagnostic techniques and neuropathologic observation in early disease.Neurology 35: 254–257, 1985.
Norstrand IF. Cerebral disorders detected by EEG and missed by CAT scan.Clinical EEG 13: 139–147, 1982.
Galvez S, Cartier L, Computed tomography findings in 15 cases of Creutzfeldt-Jakob disease with histological verification.J Neurol Neurosurg Psychiatry 47: 1244–1246, 1984.
Shin WJ, Markesbery WR, Clark DB, Goldstein S, Domstadt PA, Coupai JJ, et al. Iodine-123 HIPDM brain imaging findings in subacute spongiform encephalopathy (Creutzfeldt-Jakob disease).J Nucl Med 28: 1484–1487, 1987.
Jibiki I, Fukushima T, Kobayashi K, Kurokawa K, Yamaguchi N, Matsuda H, et al. Utility of I-123-IMP SPECT brain scans for the early detection of site-specific abnormalities in Creutzfeldt-Jakob disease (Heidenhain type): a case study.Neuropsychobiology 29: 117–119, 1994.
Goto 1, Taniwaki T, Hosokawa S, Otsuka M, Ichiya Y, Ichimiya A. Positron emission tomography (PET) studies in dementia.J Neurol Sci 114: 1–6, 1993.
Shishido F, Uemura K, Inugami A, Tomura N, Higano S, Fujita H, et al. Brain glucose metabolism in a patient with Creutzfeldt-Jakob disease measured by positron emission tomography.KAKU IGAKU (Jpn J Nucl Med) 27: 649–654, 1990.
Heye N, Farahati J, Heinz A, Büttner T, Przuntek H, Reiners C. Topodiagnosis in Creutzfeldt-Jakob disease by HMPAO-SPECT.Nucl Med 32: 57–59, 1993.
Holthoff VA, Sandmann J, Pawlik G, Schroeder R, Heiss WD. Positron emission tomography in Creutzfeldt-Jakob disease.Arch Neurol 47: 1035–1038, 1990.
Victoroff J, Ross GW, Benson DF, Verity MA, Vinters HV. Posterior cortical atrophy. Neuropathological correlations.Arch Neurol 51: 269–274, 1994.
Aharon-Peretz J, Peretz A, Hemli JA, Honigman S, Israel O. SPECT diagnosis of Creutzfeldt-Jacob disease.J Nucl Med 36: 616–617, 1995.
Goldman S, Laird A, Flament-Durant J, Luxen A, Bidaut LM, Stanus E, et al. Positron emission tomography and histopathology in Creutzfeldt-Jakob disease.Neurology 43: 1828–1830, 1993.
Grünwald F, Menzel C, Pavics L, Bauer J, Hufnagel A, Reichmann K, et al. Ictal and interjctai brain SPECT imaging in epilepsy using technetium-99m-ECD.J Nucl Med 35: 1896–1901, 1994.
Silverman IE, Galetta SL, Gray LG, Moster M, Atlas SW, Maurer AH, et al. SPECT in patients with cortical visual loss.J Nucl Med 34: 1447–1451, 1993.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Grünwald, F., Pohl, C., Bender, H. et al. 18F-fluorodeoxyglucose-PET and99mTc-bicisate-SPECT in Creutzfeldt-Jakob disease. Ann Nucl Med 10, 131–134 (1996). https://doi.org/10.1007/BF03165066
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03165066